Agile Therapeutics Shares Outstanding 2013-2023 | AGRX
Agile Therapeutics shares outstanding from 2013 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Agile Therapeutics Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
2 |
| 2022 |
0 |
| 2021 |
0 |
| 2020 |
0 |
| 2019 |
0 |
| 2018 |
0 |
| 2017 |
0 |
| 2016 |
0 |
| 2015 |
0 |
| 2014 |
0 |
| 2013 |
0 |
| 2012 |
0 |
Agile Therapeutics Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-09-30 |
3 |
| 2023-06-30 |
2 |
| 2023-03-31 |
1 |
| 2022-12-31 |
0 |
| 2022-09-30 |
1 |
| 2022-06-30 |
0 |
| 2022-03-31 |
0 |
| 2021-12-31 |
0 |
| 2021-09-30 |
0 |
| 2021-06-30 |
0 |
| 2021-03-31 |
0 |
| 2020-12-31 |
0 |
| 2020-09-30 |
0 |
| 2020-06-30 |
0 |
| 2020-03-31 |
0 |
| 2019-12-31 |
0 |
| 2019-09-30 |
0 |
| 2019-06-30 |
0 |
| 2019-03-31 |
0 |
| 2018-12-31 |
0 |
| 2018-09-30 |
0 |
| 2018-06-30 |
0 |
| 2018-03-31 |
0 |
| 2017-12-31 |
0 |
| 2017-09-30 |
0 |
| 2017-06-30 |
0 |
| 2017-03-31 |
0 |
| 2016-12-31 |
0 |
| 2016-09-30 |
0 |
| 2016-06-30 |
0 |
| 2016-03-31 |
0 |
| 2015-12-31 |
0 |
| 2015-09-30 |
0 |
| 2015-06-30 |
0 |
| 2015-03-31 |
0 |
| 2014-12-31 |
0 |
| 2014-09-30 |
0 |
| 2014-06-30 |
0 |
| 2014-03-31 |
0 |
| 2013-12-31 |
|
| 2013-09-30 |
0 |
| 2013-06-30 |
0 |
| 2012-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
